Very early researchLooking for participantsNCT06216938What this trial is testingRP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisWho this might be right forMelanoma Yana Najjar 25
Testing effectiveness (Phase 2)Study completedNCT02030301What this trial is testingSafety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in AdultsWho this might be right forGenital Herpes Simplex Type 2 Vical 165
Post-approval studies (Phase 4)Study completedNCT00820534What this trial is testingA Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore SufferersWho this might be right forCold Sore Novartis 126
Large-scale testing (Phase 3)Study completedNCT00224471What this trial is testingStudy to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex VaccineWho this might be right forHerpes Simplex GlaxoSmithKline 671
Early research (Phase 1)Study completedNCT03661541What this trial is testingImmune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)Who this might be right forHSVHerpes Labialis Squarex, LLC 36
Early research (Phase 1)Study completedNCT00002116What this trial is testingA Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDSWho this might be right forHerpes SimplexHIV Infections Gilead Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT04539483What this trial is testingMonoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 InfectionWho this might be right forHerpes Labialis Heidelberg ImmunoTherapeutics GmbH 761
Large-scale testing (Phase 3)Study completedNCT00561080What this trial is testingImmunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)Who this might be right forPrevention of : Herpes-Zoster Merck Sharp & Dohme LLC 759
Not applicableWithdrawnNCT03421548What this trial is testingImplantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1Who this might be right forGlaucomaBlindness, AcquiredKeratitis, Herpetic+4 more Centre hospitalier de l'Université de Montréal (CHUM)
Early research (Phase 1)Not Yet RecruitingNCT06954818What this trial is testingSafety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or MoreWho this might be right forHerpes Zoster CSPC Megalith Biopharmaceutical Co.,Ltd. 200
Early research (Phase 1)Looking for participantsNCT07076498What this trial is testingEngineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationWho this might be right forGlioma M.D. Anderson Cancer Center 20
Early research (Phase 1)Ended earlyNCT04348916What this trial is testingStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsWho this might be right forCancerMelanomaSolid Tumor+7 more Oncorus, Inc. 66
Not applicableUnknownNCT05331417What this trial is testingBronchoscopic Score for Prediction of Herpes Simplex-virus Type 1 (HSV-1) ReactivationWho this might be right forTracheobronchitisHerpes Simplex Infection University Hospital Muenster 100
Testing effectiveness (Phase 2)Study completedNCT05683834What this trial is testingTrial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative PersonsWho this might be right forEpstein-Barr Virus InfectionInfectious MononucleosisHerpesvirus National Institute of Allergy and Infectious Diseases (NIAID) 25
Post-approval studies (Phase 4)Study completedNCT00248144What this trial is testingEvaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes LabialisWho this might be right forRecurrent Herpes Labialis Novartis
Not applicableStudy completedNCT02270099What this trial is testingEvaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic SubjectsWho this might be right forHerpes Simplex Infections Hologic, Inc. 839
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07227285What this trial is testingLong-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene TherapyWho this might be right forUrinary Bladder, OveractiveSpinal Cord Injury Cyllene Therapeutics 16
Not applicableStudy completedNCT01460433What this trial is testingProblems With Immune Recovery in the Gut TissueWho this might be right forHuman Immunodeficiency Virus University of Minnesota 21
Very early researchUnknownNCT05830240What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck CancerWho this might be right forHead and Neck CancerEsophageal CancerOtorhinolaryngologic Neoplasms+4 more Shanghai Yunying Medical Technology 9
Not applicableStudy completedNCT02092233What this trial is testingA Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic PatientsWho this might be right forHerpes Luminex Corporation 1,963